31181-84-7

Basic information

• Product Name: (5-TRIFLUOROMETHYL-PYRIDIN-2-YL) METHANOL
• Synonyms: (5-TRIFLUOROMETHYL-PYRIDIN-2-YL) METHANOL;[5-(Trifluoromethyl)-2-pyridinyl]methanol;2-HydroxyMethyl-5-(TrifluorMethyl)-Pyridine;2-(Hydroxymethyl)-5-(trifluoromethyl)pyridine;5-(trifluoromethyl)-2-Pyridinemethanol
• CAS NO: 31181-84-7
• Molecular Formula: C₇H₆F₃NO
• Molecular Weight: 177.12
• Mol File: 31181-84-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 215.5ºC at 760 mmHg
• Flash Point: 84.1ºC
• Appearance: /
• Density: 1.362g/cm3
• Vapor Pressure: 0.0862mmHg at 25°C
• Refractive Index: 1.462
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 13.16±0.10(Predicted)
• CAS DataBase Reference: (5-TRIFLUOROMETHYL-PYRIDIN-2-YL) METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (5-TRIFLUOROMETHYL-PYRIDIN-2-YL) METHANOL(31181-84-7)
• EPA Substance Registry System: (5-TRIFLUOROMETHYL-PYRIDIN-2-YL) METHANOL(31181-84-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 31181-84-7(Hazardous Substances Data)

Usage

General Description

(5-TRIFLUOROMETHYL-PYRIDIN-2-YL) METHANOL is a chemical compound with the molecular formula C7H6F3NO. It is a pyridine derivative with a trifluoromethyl group attached to the 5-position and a methanol group attached to the 2-position. (5-TRIFLUOROMETHYL-PYRIDIN-2-YL) METHANOL is commonly used in organic synthesis and medicinal chemistry as a building block for the synthesis of various pharmaceuticals and agrochemicals. It has also been studied for its potential biological activities and pharmacological properties. The trifluoromethyl group in the molecule is known to enhance the chemical and metabolic stability of the compound, making it a valuable tool in drug discovery and development.

InChI:InChI=1/C7H6F3NO/c8-7(9,10)5-1-2-6(4-12)11-3-5/h1-3,12H,4H2

Upstream product

• 541-41-3 chloroformic acid ethyl ester 
• 80194-69-0 5-(trifluoromethyl)picolinic acid 
• 67-56-1 methanol 
• 100366-75-4 2‐iodo‐5‐(trifluoromethyl)pyridine 
• 50488-42-1 2-bromo-5-(trifluoromethyl)pyridine 
• 31224-82-5 5-(trifluoromethyl)pyridine-2-carbaldehyde 
• 124236-37-9 5-(trifluoromethyl)-pyridine-2-carboxylic acid methyl ester 

Downstream Products

• 128790-14-7 5-trifluoromethyl-pyridin-2-ylmethyl chloride 
• 1000773-62-5 2-(bromomethyl)-5-(trifluoromethyl)pyridine 
• 31224-82-5 5-(trifluoromethyl)pyridine-2-carbaldehyde 

Relevant articles and documents

Micromolecular compound with anti-inflammatory activity, and preparation method and drug application of micromolecular compound

The invention relates to the field of pharmaceutical chemistry, in particular to a compound (I) with anti-inflammatory activity and a preparation method. Pharmacodynamic tests prove that the compound has PDE-4 (phosphodiesterase-4) inhibition activity and can be used for treating and preventing inflammation related diseases.

NOVEL COMPOUNDS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein L, X, Ra, Rb, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6 S)-2-nitro-6-{[4-(trifluoromethoxy) benzyl]oxy}-6,7-dihydro-5 H -imidazo[2,1- b ][1,3]oxazine (PA-824)

New analogues of antitubercular drug PA-824 were synthesized, featuring alternative side chain ether linkers of varying size and flexibility, seeking drug candidates with enhanced metabolic stability and high efficacy. Both α-methyl substitution and removal of the benzylic methylene were broadly tolerated in vitro, with a biaryl example of the latter class exhibiting an 8-fold better efficacy than the parent drug in a mouse model of acute Mycobacterium tuberculosis infection and negligible fragmentation to an alcohol metabolite in liver microsomes. Extended linkers (notably propenyloxy, propynyloxy, and pentynyloxy) provided greater potencies against replicating M. tb (monoaryl analogues), with propynyl ethers being most effective under anaerobic (nonreplicating) conditions (mono/biaryl analogues). For benzyloxybenzyl and biaryl derivatives, aerobic activity was maximal with the original (OCH2) linker. One propynyloxy-linked compound displayed an 89-fold higher efficacy than the parent drug in the acute model, and it was slightly superior to antitubercular drug OPC-67683 in a chronic infection model.